Tailorx rxponder clinical research extension award: advancing progress precision and equity in breast cancer care customer

Active Project Grant Awarded Last action

Award ID
HT94252310572
Recipient
Awarding agency
Obligated
$3,644,169

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 78% complete
Place of performance
Philadelphia, PA 19103, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded a $3,644,169 Project Grant to the ECOG-ACRIN Medical Research Foundation, Inc. to advance precision and equity in breast cancer care. This funding, provided through the Military Medical Research and Development program (CFDA 12.420), supports a 4-year clinical research extension to the TAILORx study, which aims to improve personalized treatment for breast cancer patients. As a subrecipient, the Foundation has also supported research at Dana-Farber Cancer Institute and the University of Washington by providing data management, protocol development, and other research services. The project leverages the Foundation's expertise in biomarker-driven cancer research and clinical trials to drive progress in precision medicine and real-world evidence generation for breast cancer care.

Subawards

Subrecipient Amount Awarded
Dana-Farber Cancer Institute, Inc. YR3 DoD Funding $96,823
Yale Univ DoD YR3 Funding $55,119
Coalition Of Cancer Cooperative Groups YR3 DoD Funding $39,734
Coalition Of Cancer Cooperative Groups DoD YR2 Funding $39,828
Yale Univ YR1 and YR2 Funding Dr. Pusztai, Chair of the Breast Cancer Research Committee of SWOG and an expert in Biomarker Science, will serve on the TAILORx/RxPonder… $110,238
Icahn School Of Medicine At Mount Sinai YR1 YR2 and YR3 Funding Joseph A. Sparano, MD, FACP will serve as the overall project PI, and chair of the project Steering Committee. He serves as the protocol… $258,996
Dana-Farber Cancer Institute, Inc. YR1 & YR2 Funding Dr. Robert Gray will be a member of the Scientific Steering Committee for this project. As the TAILORx statisticians, Dr. Gray and Ms.… $185,272
Emory University YR1, YR2 & YR3 Funding Dr. Kevin Kalinsky, MD, MS, Co-Investigator, is principal investigator for the RxPONDER trial (SWOG 1007). He will be involved with all… $198,224

Quick answers

Who received award HT94252310572?

HT94252310572 was awarded to Ecog-Acrin Medical Research Foundation, Inc. by Defense Health Agency (Department of Defense) on September 15, 2023.

How much is award HT94252310572 worth?

$3,644,169 has been obligated on HT94252310572.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login